Dominant optic atrophy: Culprit mitochondria in the optic nerve

G Lenaers, A Neutzner, Y Le Dantec, C Jüschke… - Progress in Retinal and …, 2021 - Elsevier
Dominant optic atrophy (DOA) is an inherited mitochondrial disease leading to specific
degeneration of retinal ganglion cells (RGCs), thus compromising transmission of visual …

Role of oxidative stress in ocular diseases associated with retinal ganglion cells degeneration

EYC Kang, PK Liu, YT Wen, PMJ Quinn, SR Levi… - Antioxidants, 2021 - mdpi.com
Ocular diseases associated with retinal ganglion cell (RGC) degeneration is the most
common neurodegenerative disorder that causes irreversible blindness worldwide. It is …

Mitochondrial retinopathies

M Zeviani, V Carelli - International journal of molecular sciences, 2021 - mdpi.com
The retina is an exquisite target for defects of oxidative phosphorylation (OXPHOS)
associated with mitochondrial impairment. Retinal involvement occurs in two ways, retinal …

Therapeutic options in hereditary optic neuropathies

G Amore, M Romagnoli, M Carbonelli, P Barboni… - Drugs, 2021 - Springer
Options for the effective treatment of hereditary optic neuropathies have been a long time
coming. The successful launch of the antioxidant idebenone for Leber's Hereditary Optic …

Understanding the molecular basis and pathogenesis of hereditary optic neuropathies: towards improved diagnosis and management

NJ Newman, P Yu-Wai-Man, V Biousse… - The Lancet …, 2023 - thelancet.com
Hereditary optic neuropathies result from defects in the human genome, both nuclear and
mitochondrial. The two main and most recognised phenotypes are dominant optic atrophy …

Mitochondria and the eye—manifestations of mitochondrial diseases and their management

BS Chen, JP Harvey, MJ Gilhooley, N Jurkute… - Eye, 2023 - nature.com
Historically, distinct mitochondrial syndromes were recognised clinically by their ocular
features. Due to their predilection for metabolically active tissue, mitochondrial diseases …

[HTML][HTML] Mitochondrial disorders

T Klopstock, C Priglinger, A Yilmaz… - Deutsches Ärzteblatt …, 2021 - ncbi.nlm.nih.gov
Background Mitochondrial disorders are among the most common heritable diseases, with
an overall lifetime risk of approximately one in 1500. Nonetheless, their diagnosis is often …

Therapeutic approaches to treat mitochondrial diseases:“one-size-fits-all” and “precision medicine” strategies

E Bottani, C Lamperti, A Prigione, V Tiranti, N Persico… - Pharmaceutics, 2020 - mdpi.com
Primary mitochondrial diseases (PMD) refer to a group of severe, often inherited genetic
conditions due to mutations in the mitochondrial genome or in the nuclear genes encoding …

Mitochondrial dynamics: molecular mechanisms, related primary mitochondrial disorders and therapeutic approaches

M Di Nottia, D Verrigni, A Torraco, T Rizza, E Bertini… - Genes, 2021 - mdpi.com
Mitochondria do not exist as individual entities in the cell—conversely, they constitute an
interconnected community governed by the constant and opposite process of fission and …

CRISPR-Cas9 correction of OPA1 c. 1334G> A: p. R445H restores mitochondrial homeostasis in dominant optic atrophy patient-derived iPSCs

PE Sladen, PRL Perdigão, G Salsbury… - … Therapy-Nucleic Acids, 2021 - cell.com
Autosomal dominant optic atrophy (DOA) is the most common inherited optic neuropathy in
the United Kingdom. DOA has an insidious onset in early childhood, typically presenting …